4
likes
0
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
Obesity Treatment Is Changing Fast: Here’s What’s Next Analytics Table
Income Estimates for Obesity Treatment Is Changing Fast: Here’s What’s Next
Based on this YouTube video's total view count of 2.65K views and industry-standard rates, the estimated total earning is $2 - $5 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Obesity Treatment Is Changing Fast: Here’s What’s Next
Explore Obesity Treatment Is Changing Fast: Here’s What’s Next with 2,652 views, 4 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.
GLP-1 medications, obesity treatment, oral weight-loss drugs, pediatric obesity care, and new therapies are changing fast. In this video, I talk about what may be coming next in obesity medicine. GLP-1 medications have changed the way we treat obesity, but they are not the end of the story. There are new medications being studied, including oral options that could make treatment more affordable and more accessible for patients. There are also new biological pathways being explored, including amylin-based treatments and medications like retatrutide, which works differently than current single or dual agonist medications. These options may eventually help patients who do not respond well to the first treatment they try. I also talk about newer surgical and endoscopic procedures, including why some options like the lap band became less popular and why procedures like endoscopic sleeve gastroplasty still need stronger long-term data, especially before we can talk seriously about using them in children. The bigger point is simple: obesity is a chronic disease, and patients need more than one option. The more science we have, the more innovation we have, and the more treatment pathways we can safely study, the better we can serve patients long term. Timestamps: 00:00 - New Obesity Treatments Are Coming Soon 00:09 - Why Oral Medications Could Improve Access 00:51 - What Retatrutide May Add to Treatment 01:37 - Why Lap Band Lost Popularity 02:13 - Endoscopic Sleeve Gastroplasty Needs More Data 02:52 - Gene Editing Is Not Ready Yet 03:20 - Why More Innovation Helps Patients Obesity Treatment Is Changing Fast: Here’s What’s Next #Obesity_Treatment_Is_Changing, #food_noise, #mounjaro_weight_loss, #Obesity_Treatment_Is_Changing_Fast, #Evan_P_Nadler_MD, #MBA, #glp-1_weight_loss, #diabetes, #ozempic, #wegovy, #weight_loss_medication, #ozempic_side_effects, #ozempic_weight_loss, #obesity, #mounjaro, #zepbound, #glp-1, #obesity_treatment, #GLP-1_agonist, #retatrutide, #tirzepatide, #Wegovy, #Ozempic, #Zepbound, #Mounjaro, #endoscopic_sleeve_gastroplasty, #childhood_obesity, #chronic_disease_treatment, #metabolic_health, #obesity_research,
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

